Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for COVID-19 Prevention in Healthcare Workers
NCT04371523Phase 3Withdrawn
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by St. Joseph's Healthcare Hamilton. Planned start May 2020; status: withdrawn.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371523.